Literature DB >> 8876063

Stimulation of gamma delta T cells by phosphoantigens.

J J Fournié1, M Bonneville.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8876063     DOI： 10.1016/0923-2494(96)89648-9

Source DB:  PubMed          Journal:  Res Immunol        ISSN： 0923-2494


× No keyword cloud information.
  22 in total

Review 1.  Human gamma delta T lymphocytes in HIV disease: effector functions and control by natural killer cell receptors.

Authors:  M L Gougeon; F Poccia; S Boullier
Journal:  Springer Semin Immunopathol       Date:  2000

2.  Assessment of tumor-infiltrating TCRVγ9Vδ2 γδ lymphocyte abundance by deconvolution of human cancers microarrays.

Authors:  Marie Tosolini; Frédéric Pont; Mary Poupot; François Vergez; Marie-Laure Nicolau-Travers; David Vermijlen; Jean-Emmanuel Sarry; Francesco Dieli; Jean-Jacques Fournié
Journal:  Oncoimmunology       Date:  2017-02-06       Impact factor: 8.110

3.  Phosphoantigen-activated V gamma 2V delta 2 T cells antagonize IL-2-induced CD4+CD25+Foxp3+ T regulatory cells in mycobacterial infection.

Authors:  Guangming Gong; Lingyun Shao; Yunqi Wang; Crystal Y Chen; Dan Huang; Shuyu Yao; Ximei Zhan; Helene Sicard; Richard Wang; Zheng W Chen
Journal:  Blood       Date:  2008-11-03       Impact factor: 22.113

4.  Immune distribution and localization of phosphoantigen-specific Vgamma2Vdelta2 T cells in lymphoid and nonlymphoid tissues in Mycobacterium tuberculosis infection.

Authors:  Dan Huang; Yun Shen; Liyou Qiu; Crystal Y Chen; Ling Shen; Jim Estep; Robert Hunt; Daphne Vasconcelos; George Du; Pyone Aye; Andrew A Lackner; Michelle H Larsen; William R Jacobs; Barton F Haynes; Norman L Letvin; Zheng W Chen
Journal:  Infect Immun       Date:  2007-10-08       Impact factor: 3.441

5.  Single-cell RNA sequencing unveils the shared and the distinct cytotoxic hallmarks of human TCRVδ1 and TCRVδ2 γδ T lymphocytes.

Authors:  Gabriele Pizzolato; Hannah Kaminski; Marie Tosolini; Don-Marc Franchini; Fréderic Pont; Fréderic Martins; Carine Valle; Delphine Labourdette; Sarah Cadot; Anne Quillet-Mary; Mary Poupot; Camille Laurent; Loic Ysebaert; Serena Meraviglia; Francesco Dieli; Pierre Merville; Pierre Milpied; Julie Déchanet-Merville; Jean-Jacques Fournié
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-22       Impact factor: 11.205

6.  Th17-related cytokines contribute to recall-like expansion/effector function of HMBPP-specific Vγ2Vδ2 T cells after Mycobacterium tuberculosis infection or vaccination.

Authors:  Hongbo Shen; Yunqi Wang; Crystal Y Chen; James Frencher; Dan Huang; Enzhuo Yang; Bridgett Ryan-Payseur; Zheng W Chen
Journal:  Eur J Immunol       Date:  2015-02       Impact factor: 5.532

7.  Expansion of Vgamma9 Vdelta2 T cells is triggered by Francisella tularensis-derived phosphoantigens in tularemia but not after tularemia vaccination.

Authors:  Y Poquet; M Kroca; F Halary; S Stenmark; M A Peyrat; M Bonneville; J J Fournié; A Sjöstedt
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

8.  A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells.

Authors:  Renée C G de Bruin; John P Veluchamy; Sinéad M Lougheed; Famke L Schneiders; Silvia Lopez-Lastra; Roeland Lameris; Anita G Stam; Zsolt Sebestyen; Jürgen Kuball; Carla F M Molthoff; Erik Hooijberg; Rob C Roovers; James P Di Santo; Paul M P van Bergen En Henegouwen; Henk M W Verheul; Tanja D de Gruijl; Hans J van der Vliet
Journal:  Oncoimmunology       Date:  2017-10-20       Impact factor: 8.110

9.  Gamma interferon production by bovine gamma delta T cells following stimulation with mycobacterial mycolylarabinogalactan peptidoglycan.

Authors:  B Vesosky; O C Turner; J Turner; I M Orme
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

10.  Phosphoantigen presentation by macrophages to mycobacterium tuberculosis--reactive Vgamma9Vdelta2+ T cells: modulation by chloroquine.

Authors:  Roxana E Rojas; Martha Torres; Jean-Jacques Fournié; Clifford V Harding; W Henry Boom
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.